{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:44:32Z","timestamp":1793281472851,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"\n Importance<\/jats:title>\n It is unknown whether intravenous thrombolysis using tenecteplase is noninferior or preferable compared with alteplase for patients with acute ischemic stroke.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine the safety and efficacy of tenecteplase compared to alteplase among patients with large vessel occlusion (LVO) stroke.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This was a prespecified analysis of the Intravenous Tenecteplase Compared With Alteplase for Acute Ischaemic Stroke in Canada (ACT) randomized clinical trial that enrolled patients from 22 primary and comprehensive stroke centers across Canada between December 10, 2019, and January 25, 2022. Patients 18 years and older with a disabling ischemic stroke within 4.5 hours of symptom onset were randomly assigned (1:1) to either intravenous tenecteplase or alteplase and were monitored for up to 120 days. Patients with baseline intracranial internal carotid artery (ICA), M1-middle cerebral artery (MCA), M2-MCA, and basilar occlusions were included in this analysis. A total of 1600 patients were enrolled, and 23 withdrew consent.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Intravenous tenecteplase (0.25 mg\/kg) vs intravenous alteplase (0.9 mg\/kg).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was the proportion of modified Rankin scale (mRS) score 0-1 at 90 days. Secondary outcomes were an mRS score from 0 to 2, mortality, and symptomatic intracerebral hemorrhage. Angiographic outcomes were successful reperfusion (extended Thrombolysis in Cerebral Infarction scale score 2b-3) on first and final angiographic acquisitions. Multivariable analyses (adjusting for age, sex, National Institute of Health Stroke Scale score, onset-to-needle time, and occlusion location) were carried out.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 1577 patients, 520 (33.0%) had LVO (median [IQR] age, 74 [64-83] years; 283 [54.4%] women): 135 (26.0%) with ICA occlusion, 237 (45.6%) with M1-MCA, 117 (22.5%) with M2-MCA, and 31 (6.0%) with basilar occlusions. The primary outcome (mRS score 0-1) was achieved in 86 participants (32.7%) in the tenecteplase group vs 76 (29.6%) in the alteplase group. Rates of mRS 0-2 (129 [49.0%] vs 131 [51.0%]), symptomatic intracerebral hemorrhage (16 [6.1%] vs 11 [4.3%]), and mortality (19.9% vs 18.1%) were similar in the tenecteplase and alteplase groups, respectively. No difference was noted in successful reperfusion rates in the first (19 [9.2%] vs 21 [10.5%]) and final angiogram (174 [84.5%] vs 177 [88.9%]) among 405 patients who underwent thrombectomy.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n The findings in this study indicate that intravenous tenecteplase conferred similar reperfusion, safety, and functional outcomes compared to alteplase among patients with LVO.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaneurol.2023.2094","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T11:30:15Z","timestamp":1688988615000},"page":"824","source":"Crossref","is-referenced-by-count":76,"title":["Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke"],"prefix":"10.1001","volume":"80","author":[{"given":"Fouzi","family":"Bala","sequence":"first","affiliation":[{"name":"Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Diagnostic and Interventional Neuroradiology Department, University Hospital of Tours, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishita","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Internal Medicine, Neurology Division, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Buck","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayoola","family":"Ademola","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelagh B.","family":"Coutts","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Hotchkiss Brain Institute, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Deschaintre","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Qu\u00e9bec, Canada"},{"name":"Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houman","family":"Khosravani","sequence":"additional","affiliation":[{"name":"Sunnybrook Health Sciences Centre and the University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramana","family":"Appireddy","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Moreau","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Sherbrooke, Sherbrooke, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Phillips","sequence":"additional","affiliation":[{"name":"Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gord","family":"Gubitz","sequence":"additional","affiliation":[{"name":"Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Tkach","sequence":"additional","affiliation":[{"name":"Kelowna General Hospital, Kelowna, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Catanese","sequence":"additional","affiliation":[{"name":"Hamilton Health Sciences Centre and McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dar","family":"Dowlatshahi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Ottawa, and the Ottawa Heart Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Medvedev","sequence":"additional","affiliation":[{"name":"University of British Columbia and the Fraser Health Authority, New Westminster, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Mandzia","sequence":"additional","affiliation":[{"name":"London Health Sciences Centre and Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Pikula","sequence":"additional","affiliation":[{"name":"Toronto Western Hospital and the University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai Jai","family":"Shankar","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Williams","sequence":"additional","affiliation":[{"name":"Queen Elizabeth Hospital, Charlottetown, Prince Edward Island, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalia S.","family":"Field","sequence":"additional","affiliation":[{"name":"Vancouver Stroke Program and the Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Manosalva Alzate","sequence":"additional","affiliation":[{"name":"Medicine Hat Regional Hospital, Medicine Hat, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffar","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Grey Nuns Community Hospital, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atif","family":"Zafar","sequence":"additional","affiliation":[{"name":"St Michael\u2019s Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oje","family":"Imoukhoude","sequence":"additional","affiliation":[{"name":"Red Deer Regional Hospital, Red Deer, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Hunter","sequence":"additional","affiliation":[{"name":"Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Alhabli","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faysal","family":"Benali","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MacKenzie","family":"Horn","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Hill","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Hotchkiss Brain Institute, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Shamy","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Ottawa, and the Ottawa Heart Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolulope T.","family":"Sajobi","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Swartz","sequence":"additional","affiliation":[{"name":"Sunnybrook Health Sciences Centre and the University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijoy K.","family":"Menon","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Hotchkiss Brain Institute, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Almekhlafi","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Hotchkiss Brain Institute, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9958","key":"noi230042r1","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"issue":"12","key":"noi230042r2","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"10347","key":"noi230042r3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0140-6736(22)01054-6","article-title":"Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.","volume":"400","author":"Menon","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"noi230042r4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s11239-022-02730-5","article-title":"The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trials.","volume":"55","author":"Abuelazm","year":"2023","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"noi230042r5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jama.2018.12498","article-title":"Association of clinical, imaging, and thrombus characteristics with recanalization of visible intracranial occlusion in patients with acute ischemic stroke.","volume":"320","author":"Menon","year":"2018","journal-title":"JAMA"},{"issue":"17","key":"noi230042r6","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1056\/NEJMoa1716405","article-title":"Tenecteplase versus alteplase before thrombectomy for ischemic stroke.","volume":"378","author":"Campbell","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"noi230042r7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5853\/jos.2018.01998","article-title":"Recanalization before thrombectomy in tenecteplase vs. alteplase-treated drip-and-ship patients.","volume":"21","author":"Seners","year":"2019","journal-title":"J Stroke"},{"issue":"6","key":"noi230042r8","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1161\/STROKEAHA.122.036929","article-title":"Role of intravenous thrombolytics prior to endovascular thrombectomy.","volume":"53","author":"Campbell","year":"2022","journal-title":"Stroke"},{"issue":"20","key":"noi230042r9","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1056\/NEJMoa2107727","article-title":"A randomized trial of intravenous alteplase before endovascular treatment for stroke.","volume":"385","author":"LeCouffe","year":"2021","journal-title":"N Engl J Med"},{"key":"noi230042r10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/17474930221125973","volume":"17","year":"2022","journal-title":"Int J Stroke"},{"issue":"4","key":"noi230042r11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/23969873221113729","article-title":"Treatment times, functional outcome, and hemorrhage rates after switching to tenecteplase for stroke thrombolysis: insights from the TETRIS registry.","volume":"7","author":"Gerschenfeld","year":"2022","journal-title":"Eur Stroke J"},{"issue":"10","key":"noi230042r12","doi-asserted-by":"publisher","first-page":"e590","DOI":"10.1161\/STROKEAHA.121.035931","article-title":"Switching to tenecteplase for stroke thrombolysis: real-world experience and outcomes in a regional stroke network.","volume":"52","author":"Mahawish","year":"2021","journal-title":"Stroke"},{"key":"noi230042r13","doi-asserted-by":"publisher","DOI":"10.1161\/SVIN.121.000447","article-title":"Alteplase compared to tenecteplase in patients with Acute Ischemic Stroke (AcT) Trial: protocol for a pragmatic registry linked randomized clinical trial.","volume":"0","author":"Sajobi","year":"2022","journal-title":"Stroke Vasc Intervent Neurol"},{"issue":"5","key":"noi230042r14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/STROKEAHA.109.571364","article-title":"Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA).","volume":"41","author":"Saver","year":"2010","journal-title":"Stroke"},{"issue":"9","key":"noi230042r15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1177\/1747493018786616","article-title":"Canadian stroke best practice recommendations for acute stroke management: prehospital, emergency department, and acute inpatient stroke care, 6th Edition, update 2018.","volume":"13","author":"Boulanger","year":"2018","journal-title":"Int J Stroke"},{"issue":"7","key":"noi230042r16","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1161\/STROKEAHA.122.038760","article-title":"Ethical justification for deferral of consent in the AcT Trial for acute ischemic stroke.","volume":"53","author":"Faris","year":"2022","journal-title":"Stroke"},{"issue":"5","key":"noi230042r17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/neurintsurg-2018-014127","article-title":"eTICI reperfusion: defining success in endovascular stroke therapy.","volume":"11","author":"Liebeskind","year":"2019","journal-title":"J Neurointerv Surg"},{"issue":"10","key":"noi230042r18","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/STROKEAHA.115.010049","article-title":"The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy.","volume":"46","author":"von Kummer","year":"2015","journal-title":"Stroke"},{"issue":"15","key":"noi230042r19","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2165\/00003088-200241150-00001","article-title":"Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction.","volume":"41","author":"Tanswell","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"22","key":"noi230042r20","doi-asserted-by":"publisher","first-page":"e2173","DOI":"10.1212\/WNL.0000000000012915","article-title":"Functional outcome, recanalization, and hemorrhage rates after large vessel occlusion stroke treated with tenecteplase before thrombectomy.","volume":"97","author":"Gerschenfeld","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"noi230042r21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ana.v93.3","article-title":"Tenecteplase improves reperfusion across time in large vessel stroke.","volume":"93","author":"Yogendrakumar","year":"2023","journal-title":"Ann Neurol"},{"issue":"1","key":"noi230042r22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1161\/STROKEAHA.120.029292","article-title":"Thrombus migration and fragmentation after intravenous alteplase treatment: the INTERRSeCT study.","volume":"52","author":"Ohara","year":"2021","journal-title":"Stroke"},{"issue":"20","key":"noi230042r23","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1212\/WNL.0000000000012796","article-title":"Thrombus composition, imaging, and outcome prediction in acute ischemic stroke.","volume":"97","author":"Joundi","year":"2021","journal-title":"Neurology"},{"issue":"6","key":"noi230042r24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1017\/cjn.2015.291","article-title":"Thrombus characteristics are related to collaterals and angioarchitecture in acute stroke.","volume":"42","author":"Qazi","year":"2015","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"noi230042r25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.4506","article-title":"Off-label use of tenecteplase for the treatment of acute ischemic stroke: a systematic review and meta-analysis.","volume":"5","author":"Katsanos","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"noi230042r26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/STROKEAHA.120.030220","article-title":"Intravenous thrombolysis with tenecteplase in patients with large vessel occlusions: systematic review and meta-analysis.","volume":"52","author":"Katsanos","year":"2021","journal-title":"Stroke"},{"issue":"10","key":"noi230042r27","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1474-4422(17)30253-3","article-title":"Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.","volume":"16","author":"Logallo","year":"2017","journal-title":"Lancet Neurol"},{"issue":"12","key":"noi230042r28","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1161\/STROKEAHA.122.038950","article-title":"Prospective observational cohort study of tenecteplase versus alteplase in routine clinical practice.","volume":"53","author":"Warach","year":"2022","journal-title":"Stroke"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2806621\/jamaneurology_bala_2023_oi_230042_1691786973.74263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T11:01:43Z","timestamp":1692010903000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2806621"}},"subtitle":["A Prespecified Secondary Analysis of the ACT Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2023.2094","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}